N-[6-bromo-1-cyclobutyl-4-(trifluoromethyl)benzimidazol-2-yl]-3,3-dimethylbutanamide;(3S)-N-[6-chloro-5-fluoro-1-(1-methylcyclobutyl)benzimidazol-2-yl]-3-hydroxy-3-phenylbutanamide;N-(1-cyclobutyl-4-fluoro-6-isocyanobenzimidazol-2-yl)-3,3-dimethylbutanamide;(3S)-N-(1-cyclobutyl-7-fluoro-6-methoxybenzimidazol-2-yl)-3-hydroxy-3-phenylbutanamide;(3R)-N-(1-cyclobutyl-7-fluoro-6-methoxybenzimidazol-2-yl)-3-hydroxy-3-phenylbutanamide;N-(1-cyclobutyl-7-fluoro-6-methylbenzimidazol-2-yl)-3-hydroxy-3-methylbutanamide;N-(1-cyclobutyl-7-fluoro-6-morpholin-4-ylbenzimidazol-2-yl)-3-hydroxy-3-methylbutanamide

C139H162BrClF9N23O15 — CID 162153692

IUPACN-[6-bromo-1-cyclobutyl-4-(trifluoromethyl)benzimidazol-2-yl]-3,3-dimethylbutanamide;(3S)-N-[6-chloro-5-fluoro-1-(1-methylcyclobutyl)benzimidazol-2-yl]-3-hydroxy-3-phenylbutanamide;N-(1-cyclobutyl-4-fluoro-6-isocyanobenzimidazol-2-yl)-3,3-dimethylbutanamide;(3S)-N-(1-cyclobutyl-7-fluoro-6-methoxybenzimidazol-2-yl)-3-hydroxy-3-phenylbutanamide;(3R)-N-(1-cyclobutyl-7-fluoro-6-methoxybenzimidazol-2-yl)-3-hydroxy-3-phenylbutanamide;N-(1-cyclobutyl-7-fluoro-6-methylbenzimidazol-2-yl)-3-hydroxy-3-methylbutanamide;N-(1-cyclobutyl-7-fluoro-6-morpholin-4-ylbenzimidazol-2-yl)-3-hydroxy-3-methylbutanamide
SMILESCC(C)(C)CC(=O)Nc1nc2c(C(F)(F)F)cc(Br)cc2n1C1CCC1.CC(C)(O)CC(=O)Nc1nc2ccc(N3CCOCC3)c(F)c2n1C1CCC1.CC1(n2c(NC(=O)C[C@](C)(O)c3ccccc3)nc3cc(F)c(Cl)cc32)CCC1.COc1ccc2nc(NC(=O)C[C@@](C)(O)c3ccccc3)n(C3CCC3)c2c1F.COc1ccc2nc(NC(=O)C[C@](C)(O)c3ccccc3)n(C3CCC3)c2c1F.Cc1ccc2nc(NC(=O)CC(C)(C)O)n(C3CCC3)c2c1F.[C-]#[N+]c1cc(F)c2nc(NC(=O)CC(C)(C)C)n(C3CCC3)c2c1
InChIInChI=1S/C22H23ClFN3O2.2C22H24FN3O3.C20H27FN4O3.C18H21BrF3N3O.C18H21FN4O.C17H22FN3O2/c1-21(9-6-10-21)27-18-11-15(23)16(24)12-17(18)25-20(27)26-19(28)13-22(2,29)14-7-4-3-5-8-14;2*1-22(28,14-7-4-3-5-8-14)13-18(27)25-21-24-16-11-12-17(29-2)19(23)20(16)26(21)15-9-6-10-15;1-20(2,27)12-16(26)23-19-22-14-6-7-15(24-8-10-28-11-9-24)17(21)18(14)25(19)13-4-3-5-13;1-17(2,3)9-14(26)23-16-24-15-12(18(20,21)22)7-10(19)8-13(15)25(16)11-5-4-6-11;1-18(2,3)10-15(24)21-17-22-16-13(19)8-11(20-4)9-14(16)23(17)12-6-5-7-12;1-10-7-8-12-15(14(10)18)21(11-5-4-6-11)16(19-12)20-13(22)9-17(2,3)23/h3-5,7-8,11-12,29H,6,9-10,13H2,1-2H3,(H,25,26,28);2*3-5,7-8,11-12,15,28H,6,9-10,13H2,1-2H3,(H,24,25,27);6-7,13,27H,3-5,8-12H2,1-2H3,(H,22,23,26);7-8,11H,4-6,9H2,1-3H3,(H,23,24,26);8-9,12H,5-7,10H2,1-3H3,(H,21,22,24);7-8,11,23H,4-6,9H2,1-3H3,(H,19,20,22)/t3*22-;;;;/m010..../s1
InChIKeyZLNUZUPSCHDMHT-YSZRQVJWSA-N
MW2681.31 g/mol
LogP30.14
Rot. Bonds32

About N-[6-bromo-1-cyclobutyl-4-(trifluoromethyl)benzimidazol-2-yl]-3,3-dimethylbutanamide;(3S)-N-[6-chloro-5-fluoro-1-(1-methylcyclobutyl)benzimidazol-2-yl]-3-hydroxy-3-phenylbutanamide;N-(1-cyclobutyl-4-fluoro-6-isocyanobenzimidazol-2-yl)-3,3-dimethylbutanamide;(3S)-N-(1-cyclobutyl-7-fluoro-6-methoxybenzimidazol-2-yl)-3-hydroxy-3-phenylbutanamide;(3R)-N-(1-cyclobutyl-7-fluoro-6-methoxybenzimidazol-2-yl)-3-hydroxy-3-phenylbutanamide;N-(1-cyclobutyl-7-fluoro-6-methylbenzimidazol-2-yl)-3-hydroxy-3-methylbutanamide;N-(1-cyclobutyl-7-fluoro-6-morpholin-4-ylbenzimidazol-2-yl)-3-hydroxy-3-methylbutanamide

N-[6-bromo-1-cyclobutyl-4-(trifluoromethyl)benzimidazol-2-yl]-3,3-dimethylbutanamide;(3S)-N-[6-chloro-5-fluoro-1-(1-methylcyclobutyl)benzimidazol-2-yl]-3-hydroxy-3-phenylbutanamide;N-(1-cyclobutyl-4-fluoro-6-isocyanobenzimidazol-2-yl)-3,3-dimethylbutanamide;(3S)-N-(1-cyclobutyl-7-fluoro-6-methoxybenzimidazol-2-yl)-3-hydroxy-3-phenylbutanamide;(3R)-N-(1-cyclobutyl-7-fluoro-6-methoxybenzimidazol-2-yl)-3-hydroxy-3-phenylbutanamide;N-(1-cyclobutyl-7-fluoro-6-methylbenzimidazol-2-yl)-3-hydroxy-3-methylbutanamide;N-(1-cyclobutyl-7-fluoro-6-morpholin-4-ylbenzimidazol-2-yl)-3-hydroxy-3-methylbutanamide (PubChem CID 162153692) has the molecular formula C139H162BrClF9N23O15 and a molecular weight of 2681.31 g/mol. Its IUPAC name is N-[6-bromo-1-cyclobutyl-4-(trifluoromethyl)benzimidazol-2-yl]-3,3-dimethylbutanamide;(3S)-N-[6-chloro-5-fluoro-1-(1-methylcyclobutyl)benzimidazol-2-yl]-3-hydroxy-3-phenylbutanamide;N-(1-cyclobutyl-4-fluoro-6-isocyanobenzimidazol-2-yl)-3,3-dimethylbutanamide;(3S)-N-(1-cyclobutyl-7-fluoro-6-methoxybenzimidazol-2-yl)-3-hydroxy-3-phenylbutanamide;(3R)-N-(1-cyclobutyl-7-fluoro-6-methoxybenzimidazol-2-yl)-3-hydroxy-3-phenylbutanamide;N-(1-cyclobutyl-7-fluoro-6-methylbenzimidazol-2-yl)-3-hydroxy-3-methylbutanamide;N-(1-cyclobutyl-7-fluoro-6-morpholin-4-ylbenzimidazol-2-yl)-3-hydroxy-3-methylbutanamide.

Molecular Properties

Compound NameN-[6-bromo-1-cyclobutyl-4-(trifluoromethyl)benzimidazol-2-yl]-3,3-dimethylbutanamide;(3S)-N-[6-chloro-5-fluoro-1-(1-methylcyclobutyl)benzimidazol-2-yl]-3-hydroxy-3-phenylbutanamide;N-(1-cyclobutyl-4-fluoro-6-isocyanobenzimidazol-2-yl)-3,3-dimethylbutanamide;(3S)-N-(1-cyclobutyl-7-fluoro-6-methoxybenzimidazol-2-yl)-3-hydroxy-3-phenylbutanamide;(3R)-N-(1-cyclobutyl-7-fluoro-6-methoxybenzimidazol-2-yl)-3-hydroxy-3-phenylbutanamide;N-(1-cyclobutyl-7-fluoro-6-methylbenzimidazol-2-yl)-3-hydroxy-3-methylbutanamide;N-(1-cyclobutyl-7-fluoro-6-morpholin-4-ylbenzimidazol-2-yl)-3-hydroxy-3-methylbutanamide
PubChem CID162153692
Molecular FormulaC139H162BrClF9N23O15
Molecular Weight2681.31 g/mol
Exact Mass2678.13
IUPAC NameN-[6-bromo-1-cyclobutyl-4-(trifluoromethyl)benzimidazol-2-yl]-3,3-dimethylbutanamide;(3S)-N-[6-chloro-5-fluoro-1-(1-methylcyclobutyl)benzimidazol-2-yl]-3-hydroxy-3-phenylbutanamide;N-(1-cyclobutyl-4-fluoro-6-isocyanobenzimidazol-2-yl)-3,3-dimethylbutanamide;(3S)-N-(1-cyclobutyl-7-fluoro-6-methoxybenzimidazol-2-yl)-3-hydroxy-3-phenylbutanamide;(3R)-N-(1-cyclobutyl-7-fluoro-6-methoxybenzimidazol-2-yl)-3-hydroxy-3-phenylbutanamide;N-(1-cyclobutyl-7-fluoro-6-methylbenzimidazol-2-yl)-3-hydroxy-3-methylbutanamide;N-(1-cyclobutyl-7-fluoro-6-morpholin-4-ylbenzimidazol-2-yl)-3-hydroxy-3-methylbutanamide
SMILESCC(C)(C)CC(=O)Nc1nc2c(C(F)(F)F)cc(Br)cc2n1C1CCC1.CC(C)(O)CC(=O)Nc1nc2ccc(N3CCOCC3)c(F)c2n1C1CCC1.CC1(n2c(NC(=O)C[C@](C)(O)c3ccccc3)nc3cc(F)c(Cl)cc32)CCC1.COc1ccc2nc(NC(=O)C[C@@](C)(O)c3ccccc3)n(C3CCC3)c2c1F.COc1ccc2nc(NC(=O)C[C@](C)(O)c3ccccc3)n(C3CCC3)c2c1F.Cc1ccc2nc(NC(=O)CC(C)(C)O)n(C3CCC3)c2c1F.[C-]#[N+]c1cc(F)c2nc(NC(=O)CC(C)(C)C)n(C3CCC3)c2c1
InChIInChI=1S/C22H23ClFN3O2.2C22H24FN3O3.C20H27FN4O3.C18H21BrF3N3O.C18H21FN4O.C17H22FN3O2/c1-21(9-6-10-21)27-18-11-15(23)16(24)12-17(18)25-20(27)26-19(28)13-22(2,29)14-7-4-3-5-8-14;2*1-22(28,14-7-4-3-5-8-14)13-18(27)25-21-24-16-11-12-17(29-2)19(23)20(16)26(21)15-9-6-10-15;1-20(2,27)12-16(26)23-19-22-14-6-7-15(24-8-10-28-11-9-24)17(21)18(14)25(19)13-4-3-5-13;1-17(2,3)9-14(26)23-16-24-15-12(18(20,21)22)7-10(19)8-13(15)25(16)11-5-4-6-11;1-18(2,3)10-15(24)21-17-22-16-13(19)8-11(20-4)9-14(16)23(17)12-6-5-7-12;1-10-7-8-12-15(14(10)18)21(11-5-4-6-11)16(19-12)20-13(22)9-17(2,3)23/h3-5,7-8,11-12,29H,6,9-10,13H2,1-2H3,(H,25,26,28);2*3-5,7-8,11-12,15,28H,6,9-10,13H2,1-2H3,(H,24,25,27);6-7,13,27H,3-5,8-12H2,1-2H3,(H,22,23,26);7-8,11H,4-6,9H2,1-3H3,(H,23,24,26);8-9,12H,5-7,10H2,1-3H3,(H,21,22,24);7-8,11,23H,4-6,9H2,1-3H3,(H,19,20,22)/t3*22-;;;;/m010..../s1
InChIKeyZLNUZUPSCHDMHT-YSZRQVJWSA-N
XLogP30.14
TPSA464.88 Ų
H-Bond Donors12
H-Bond Acceptors30
Rotatable Bonds32
Heavy Atoms188
Complexity—

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5002681.31
LogP ≤ 530.14
H-Bond Donors ≤ 512
H-Bond Acceptors ≤ 1030

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Carbo_cation/anion', 'substructure': 'N/A'}

Analyze N-[6-bromo-1-cyclobutyl-4-(trifluoromethyl)benzimidazol-2-yl]-3,3-dimethylbutanamide;(3S)-N-[6-chloro-5-fluoro-1-(1-methylcyclobutyl)benzimidazol-2-yl]-3-hydroxy-3-phenylbutanamide;N-(1-cyclobutyl-4-fluoro-6-isocyanobenzimidazol-2-yl)-3,3-dimethylbutanamide;(3S)-N-(1-cyclobutyl-7-fluoro-6-methoxybenzimidazol-2-yl)-3-hydroxy-3-phenylbutanamide;(3R)-N-(1-cyclobutyl-7-fluoro-6-methoxybenzimidazol-2-yl)-3-hydroxy-3-phenylbutanamide;N-(1-cyclobutyl-7-fluoro-6-methylbenzimidazol-2-yl)-3-hydroxy-3-methylbutanamide;N-(1-cyclobutyl-7-fluoro-6-morpholin-4-ylbenzimidazol-2-yl)-3-hydroxy-3-methylbutanamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of N-[6-bromo-1-cyclobutyl-4-(trifluoromethyl)benzimidazol-2-yl]-3,3-dimethylbutanamide;(3S)-N-[6-chloro-5-fluoro-1-(1-methylcyclobutyl)benzimidazol-2-yl]-3-hydroxy-3-phenylbutanamide;N-(1-cyclobutyl-4-fluoro-6-isocyanobenzimidazol-2-yl)-3,3-dimethylbutanamide;(3S)-N-(1-cyclobutyl-7-fluoro-6-methoxybenzimidazol-2-yl)-3-hydroxy-3-phenylbutanamide;(3R)-N-(1-cyclobutyl-7-fluoro-6-methoxybenzimidazol-2-yl)-3-hydroxy-3-phenylbutanamide;N-(1-cyclobutyl-7-fluoro-6-methylbenzimidazol-2-yl)-3-hydroxy-3-methylbutanamide;N-(1-cyclobutyl-7-fluoro-6-morpholin-4-ylbenzimidazol-2-yl)-3-hydroxy-3-methylbutanamide?
The IUPAC name of N-[6-bromo-1-cyclobutyl-4-(trifluoromethyl)benzimidazol-2-yl]-3,3-dimethylbutanamide;(3S)-N-[6-chloro-5-fluoro-1-(1-methylcyclobutyl)benzimidazol-2-yl]-3-hydroxy-3-phenylbutanamide;N-(1-cyclobutyl-4-fluoro-6-isocyanobenzimidazol-2-yl)-3,3-dimethylbutanamide;(3S)-N-(1-cyclobutyl-7-fluoro-6-methoxybenzimidazol-2-yl)-3-hydroxy-3-phenylbutanamide;(3R)-N-(1-cyclobutyl-7-fluoro-6-methoxybenzimidazol-2-yl)-3-hydroxy-3-phenylbutanamide;N-(1-cyclobutyl-7-fluoro-6-methylbenzimidazol-2-yl)-3-hydroxy-3-methylbutanamide;N-(1-cyclobutyl-7-fluoro-6-morpholin-4-ylbenzimidazol-2-yl)-3-hydroxy-3-methylbutanamide (CID 162153692) is N-[6-bromo-1-cyclobutyl-4-(trifluoromethyl)benzimidazol-2-yl]-3,3-dimethylbutanamide;(3S)-N-[6-chloro-5-fluoro-1-(1-methylcyclobutyl)benzimidazol-2-yl]-3-hydroxy-3-phenylbutanamide;N-(1-cyclobutyl-4-fluoro-6-isocyanobenzimidazol-2-yl)-3,3-dimethylbutanamide;(3S)-N-(1-cyclobutyl-7-fluoro-6-methoxybenzimidazol-2-yl)-3-hydroxy-3-phenylbutanamide;(3R)-N-(1-cyclobutyl-7-fluoro-6-methoxybenzimidazol-2-yl)-3-hydroxy-3-phenylbutanamide;N-(1-cyclobutyl-7-fluoro-6-methylbenzimidazol-2-yl)-3-hydroxy-3-methylbutanamide;N-(1-cyclobutyl-7-fluoro-6-morpholin-4-ylbenzimidazol-2-yl)-3-hydroxy-3-methylbutanamide.
What is the SMILES notation for N-[6-bromo-1-cyclobutyl-4-(trifluoromethyl)benzimidazol-2-yl]-3,3-dimethylbutanamide;(3S)-N-[6-chloro-5-fluoro-1-(1-methylcyclobutyl)benzimidazol-2-yl]-3-hydroxy-3-phenylbutanamide;N-(1-cyclobutyl-4-fluoro-6-isocyanobenzimidazol-2-yl)-3,3-dimethylbutanamide;(3S)-N-(1-cyclobutyl-7-fluoro-6-methoxybenzimidazol-2-yl)-3-hydroxy-3-phenylbutanamide;(3R)-N-(1-cyclobutyl-7-fluoro-6-methoxybenzimidazol-2-yl)-3-hydroxy-3-phenylbutanamide;N-(1-cyclobutyl-7-fluoro-6-methylbenzimidazol-2-yl)-3-hydroxy-3-methylbutanamide;N-(1-cyclobutyl-7-fluoro-6-morpholin-4-ylbenzimidazol-2-yl)-3-hydroxy-3-methylbutanamide?
The canonical SMILES for N-[6-bromo-1-cyclobutyl-4-(trifluoromethyl)benzimidazol-2-yl]-3,3-dimethylbutanamide;(3S)-N-[6-chloro-5-fluoro-1-(1-methylcyclobutyl)benzimidazol-2-yl]-3-hydroxy-3-phenylbutanamide;N-(1-cyclobutyl-4-fluoro-6-isocyanobenzimidazol-2-yl)-3,3-dimethylbutanamide;(3S)-N-(1-cyclobutyl-7-fluoro-6-methoxybenzimidazol-2-yl)-3-hydroxy-3-phenylbutanamide;(3R)-N-(1-cyclobutyl-7-fluoro-6-methoxybenzimidazol-2-yl)-3-hydroxy-3-phenylbutanamide;N-(1-cyclobutyl-7-fluoro-6-methylbenzimidazol-2-yl)-3-hydroxy-3-methylbutanamide;N-(1-cyclobutyl-7-fluoro-6-morpholin-4-ylbenzimidazol-2-yl)-3-hydroxy-3-methylbutanamide is CC(C)(C)CC(=O)Nc1nc2c(C(F)(F)F)cc(Br)cc2n1C1CCC1.CC(C)(O)CC(=O)Nc1nc2ccc(N3CCOCC3)c(F)c2n1C1CCC1.CC1(n2c(NC(=O)C[C@](C)(O)c3ccccc3)nc3cc(F)c(Cl)cc32)CCC1.COc1ccc2nc(NC(=O)C[C@@](C)(O)c3ccccc3)n(C3CCC3)c2c1F.COc1ccc2nc(NC(=O)C[C@](C)(O)c3ccccc3)n(C3CCC3)c2c1F.Cc1ccc2nc(NC(=O)CC(C)(C)O)n(C3CCC3)c2c1F.[C-]#[N+]c1cc(F)c2nc(NC(=O)CC(C)(C)C)n(C3CCC3)c2c1.
What is the InChIKey of N-[6-bromo-1-cyclobutyl-4-(trifluoromethyl)benzimidazol-2-yl]-3,3-dimethylbutanamide;(3S)-N-[6-chloro-5-fluoro-1-(1-methylcyclobutyl)benzimidazol-2-yl]-3-hydroxy-3-phenylbutanamide;N-(1-cyclobutyl-4-fluoro-6-isocyanobenzimidazol-2-yl)-3,3-dimethylbutanamide;(3S)-N-(1-cyclobutyl-7-fluoro-6-methoxybenzimidazol-2-yl)-3-hydroxy-3-phenylbutanamide;(3R)-N-(1-cyclobutyl-7-fluoro-6-methoxybenzimidazol-2-yl)-3-hydroxy-3-phenylbutanamide;N-(1-cyclobutyl-7-fluoro-6-methylbenzimidazol-2-yl)-3-hydroxy-3-methylbutanamide;N-(1-cyclobutyl-7-fluoro-6-morpholin-4-ylbenzimidazol-2-yl)-3-hydroxy-3-methylbutanamide?
The InChIKey is ZLNUZUPSCHDMHT-YSZRQVJWSA-N. The full InChI is InChI=1S/C22H23ClFN3O2.2C22H24FN3O3.C20H27FN4O3.C18H21BrF3N3O.C18H21FN4O.C17H22FN3O2/c1-21(9-6-10-21)27-18-11-15(23)16(24)12-17(18)25-20(27)26-19(28)13-22(2,29)14-7-4-3-5-8-14;2*1-22(28,14-7-4-3-5-8-14)13-18(27)25-21-24-16-11-12-17(29-2)19(23)20(16)26(21)15-9-6-10-15;1-20(2,27)12-16(26)23-19-22-14-6-7-15(24-8-10-28-11-9-24)17(21)18(14)25(19)13-4-3-5-13;1-17(2,3)9-14(26)23-16-24-15-12(18(20,21)22)7-10(19)8-13(15)25(16)11-5-4-6-11;1-18(2,3)10-15(24)21-17-22-16-13(19)8-11(20-4)9-14(16)23(17)12-6-5-7-12;1-10-7-8-12-15(14(10)18)21(11-5-4-6-11)16(19-12)20-13(22)9-17(2,3)23/h3-5,7-8,11-12,29H,6,9-10,13H2,1-2H3,(H,25,26,28);2*3-5,7-8,11-12,15,28H,6,9-10,13H2,1-2H3,(H,24,25,27);6-7,13,27H,3-5,8-12H2,1-2H3,(H,22,23,26);7-8,11H,4-6,9H2,1-3H3,(H,23,24,26);8-9,12H,5-7,10H2,1-3H3,(H,21,22,24);7-8,11,23H,4-6,9H2,1-3H3,(H,19,20,22)/t3*22-;;;;/m010..../s1.
What are the key properties of N-[6-bromo-1-cyclobutyl-4-(trifluoromethyl)benzimidazol-2-yl]-3,3-dimethylbutanamide;(3S)-N-[6-chloro-5-fluoro-1-(1-methylcyclobutyl)benzimidazol-2-yl]-3-hydroxy-3-phenylbutanamide;N-(1-cyclobutyl-4-fluoro-6-isocyanobenzimidazol-2-yl)-3,3-dimethylbutanamide;(3S)-N-(1-cyclobutyl-7-fluoro-6-methoxybenzimidazol-2-yl)-3-hydroxy-3-phenylbutanamide;(3R)-N-(1-cyclobutyl-7-fluoro-6-methoxybenzimidazol-2-yl)-3-hydroxy-3-phenylbutanamide;N-(1-cyclobutyl-7-fluoro-6-methylbenzimidazol-2-yl)-3-hydroxy-3-methylbutanamide;N-(1-cyclobutyl-7-fluoro-6-morpholin-4-ylbenzimidazol-2-yl)-3-hydroxy-3-methylbutanamide?
N-[6-bromo-1-cyclobutyl-4-(trifluoromethyl)benzimidazol-2-yl]-3,3-dimethylbutanamide;(3S)-N-[6-chloro-5-fluoro-1-(1-methylcyclobutyl)benzimidazol-2-yl]-3-hydroxy-3-phenylbutanamide;N-(1-cyclobutyl-4-fluoro-6-isocyanobenzimidazol-2-yl)-3,3-dimethylbutanamide;(3S)-N-(1-cyclobutyl-7-fluoro-6-methoxybenzimidazol-2-yl)-3-hydroxy-3-phenylbutanamide;(3R)-N-(1-cyclobutyl-7-fluoro-6-methoxybenzimidazol-2-yl)-3-hydroxy-3-phenylbutanamide;N-(1-cyclobutyl-7-fluoro-6-methylbenzimidazol-2-yl)-3-hydroxy-3-methylbutanamide;N-(1-cyclobutyl-7-fluoro-6-morpholin-4-ylbenzimidazol-2-yl)-3-hydroxy-3-methylbutanamide has a molecular weight of 2681.31 g/mol, XLogP of 30.14, 32 rotatable bonds, 12 hydrogen bond donors, and 30 hydrogen bond acceptors.
Where does this data come from?
All data for N-[6-bromo-1-cyclobutyl-4-(trifluoromethyl)benzimidazol-2-yl]-3,3-dimethylbutanamide;(3S)-N-[6-chloro-5-fluoro-1-(1-methylcyclobutyl)benzimidazol-2-yl]-3-hydroxy-3-phenylbutanamide;N-(1-cyclobutyl-4-fluoro-6-isocyanobenzimidazol-2-yl)-3,3-dimethylbutanamide;(3S)-N-(1-cyclobutyl-7-fluoro-6-methoxybenzimidazol-2-yl)-3-hydroxy-3-phenylbutanamide;(3R)-N-(1-cyclobutyl-7-fluoro-6-methoxybenzimidazol-2-yl)-3-hydroxy-3-phenylbutanamide;N-(1-cyclobutyl-7-fluoro-6-methylbenzimidazol-2-yl)-3-hydroxy-3-methylbutanamide;N-(1-cyclobutyl-7-fluoro-6-morpholin-4-ylbenzimidazol-2-yl)-3-hydroxy-3-methylbutanamide is sourced from PubChem (CID 162153692), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).